Platinum Investment Management LTD Ironwood Pharmaceuticals Inc Transaction History

Platinum Investment Management LTD

  • $2.16 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$7.8 - $16.13 $535,080 - $1.11 Million
-68,600 Closed
0 $0
Q3 2018

Nov 15, 2018
SELL
$14.31 - $17.65 $173,151 - $213,564
-12,100 Reduced 14.99%
68,600 $1.27 Million
Q2 2018

Aug 15, 2018
SELL
$11.83 - $16.2 $281,554 - $385,560
-23,800 Reduced 22.78%
80,700 $1.54 Million
Q2 2017

Aug 15, 2017
BUY
N/A
104,500
104,500 $1.97 Million

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $527M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email